JW (Cayman) Therapeutics Co (JW (Cayman) Therapeutics Co) Days Sales Outstanding : 0.00 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is JW (Cayman) Therapeutics Co Days Sales Outstanding?

JW (Cayman) Therapeutics Co's average Accounts Receivable for the six months ended in Dec. 2023 was $0.00 Mil. JW (Cayman) Therapeutics Co's Revenue for the six months ended in Dec. 2023 was $0.00 Mil.

The historical rank and industry rank for JW (Cayman) Therapeutics Co's Days Sales Outstanding or its related term are showing as below:

JWCTF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 11.37 Med: 12.33 Max: 13.29
Current: 12.84

During the past 6 years, JW (Cayman) Therapeutics Co's highest Days Sales Outstanding was 13.29. The lowest was 11.37. And the median was 12.33.

JWCTF's Days Sales Outstanding is ranked better than
94.19% of 895 companies
in the Biotechnology industry
Industry Median: 72.67 vs JWCTF: 12.84

JW (Cayman) Therapeutics Co's Days Sales Outstanding declined from Dec. 2022 (13.28) to Dec. 2023 (0.00).

JW (Cayman) Therapeutics Co Days Sales Outstanding Historical Data

The historical data trend for JW (Cayman) Therapeutics Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW (Cayman) Therapeutics Co Days Sales Outstanding Chart

JW (Cayman) Therapeutics Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

13.29

11.41

JW (Cayman) Therapeutics Co Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial						-	16.72	13.28	11.34	-

Competitive Comparison of JW (Cayman) Therapeutics Co's Days Sales Outstanding

For the Biotechnology subindustry, JW (Cayman) Therapeutics Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JW (Cayman) Therapeutics Co's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, JW (Cayman) Therapeutics Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where JW (Cayman) Therapeutics Co's Days Sales Outstanding falls into.

JW (Cayman) Therapeutics Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

JW (Cayman) Therapeutics Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.761	+	0)	/	1 )	/	24.349	*	365
=	0.761					/	24.349	*	365
=	11.41

JW (Cayman) Therapeutics Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 2
=	0					/	0	*	365 / 2
=	N/A

JW (Cayman) Therapeutics Co (OTCPK:JWCTF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

JW (Cayman) Therapeutics Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of JW (Cayman) Therapeutics Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

JW (Cayman) Therapeutics Co (JW (Cayman) Therapeutics Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » JW (Cayman) Therapeutics Co Ltd (OTCPK:JWCTF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

02126:Hong Kong

Address

No. 699 Zhong Ke Road, 5F, Building B, Pudong New District, Shanghai, CHN

Website

https://www.jwtherapeutics.com

JW (Cayman) Therapeutics Co Ltd is a clinical-stage cell therapy company in China. It focuses on developing, manufacturing, and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors. Its lead product candidate is relmacabtagene autoleucel, which is a potential superior anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy intended for the treatment of a range of hematological cancers.

JW (Cayman) Therapeutics Co (JW (Cayman) Therapeutics Co) Headlines

No Headlines